gsk and other pharmas will do well out of their vaccine production regardless of cancelations - they will only lose money on vaccines not yet produced and shipped. (cancellation of unfilled orders) they will make a motsa out of the balance and make even more when the virus mutates and the vaccv has to be re created.
The slow production-delivery in the face of another potentially more lethal pandemic will help anti-viral market no end.Antiviral strategies will be strengthened.
did the telegraph send a reply?
- Forums
- ASX - By Stock
- more confusion over vaccine vs antiviral
gsk and other pharmas will do well out of their vaccine...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online